1. Canada Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
enGene Holdings Inc. Warrants

enGene Holdings Inc. Warrants

ENGNW
enGene Holdings Inc. WarrantsUS flagNASDAQ Capital Market
0.21
USD
-0.01
- -
10.75MMarket Cap

Total Valuation

enGene Holdings Inc. Warrants carries a market capitalization of 10.75M, placing it among publicly traded companies globally. Its enterprise value stands at -91.14M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap10.75M
Enterprise Value-91.14M

Share Statistics

enGene Holdings Inc. Warrants currently has 66.99M shares outstanding.

Shares Outstanding66.99M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

PE RatioN/A
PS RatioN/A
PB Ratio0.53
P/TBV Ratio0.53
P/FCF RatioN/A
P/OCF RatioN/A

Financial Position

enGene Holdings Inc. Warrants maintains a current ratio of 12.57, meaning it holds 12.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 13.07, indicating elevated leverage, while an interest coverage ratio of -44.19 demonstrates limited ability to service its debt obligations.

Current Ratio12.57
Quick Ratio12.07
Debt / Equity13.07
Debt / EBITDA-0.25
Interest Coverage-44.19

Financial Efficiency

Return on Equity (ROE)-52.58
Return on Assets (ROA)-44.19
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)N/A
Revenue Per EmployeeN/A
Employee CountN/A
Inventory TurnoverN/A

Taxes

Income Tax-258,000.00
Effective Tax RateN/A

Stock Price Statistics

enGene Holdings Inc. Warrants's stock has declined approximately -67.69231% over the past 52 weeks. The 50-day moving average sits at 0.64, while the 200-day moving average is 1.92.

Beta (5Y)N/A
52-Week Price Change-67.69231%
50-Day Moving Average0.64
200-Day Moving Average1.92
Average Volume (20 Days)N/A

Income Statement

EBITDA reached -131.91M, while operating income came in at -132.58M.

RevenueN/A
Gross ProfitN/A
Operating Income-132.58M
Pretax Income-127.11M
Net Income-126.85M
EBITDA-131.91M
EBIT-132.58M
Earnings Per Share (EPS)N/A

Balance Sheet

enGene Holdings Inc. Warrants holds 258.47M in cash and equivalents against 33.35M in total debt, resulting in a net debt position of -4.72M. Total book value stands at 255.17M, with working capital of 248.52M providing operational flexibility.

Cash & Cash Equivalents258.47M
Total Debt33.35M
Net Debt-4.72M
Equity (Book Value)255.17M
Book Value Per Share3.81
Working Capital248.52M

Cash Flow

enGene Holdings Inc. Warrants produced -110.00M in operating cash flow over the past twelve months.

Operating Cash Flow-110.00M
Capital Expenditures-1.39M
Free Cash Flow-111.39M
FCF Per ShareN/A

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield-106.78
FCF YieldN/A

Scores

enGene Holdings Inc. Warrants posts an Altman Z-Score of -0.88, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-0.88